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Deubiquitinating enzymes (DUBs) act on ubiquitinated substrates to regulate their modification 
and stability. In this issue, Sowa et al. (2009) present a comprehensive proteomic analysis of 
DUB interacting proteins in humans and a new quantitative scoring system for hits (CompPASS), 
providing a resource that links DUBs to biological pathways.The reversible, covalent addition of ubiq-
uitin to target proteins is a highly con-
served and flexible regulatory mecha-
nism. Monoubiquitination can change the 
activity of a ubiquinated target protein, 
whereas the addition of a ubiquitin chain 
can direct a protein to the 26S protea-
some for rapid proteolytic degradation. 
Many proteins are modified by ubiquitin 
or ubiquitin-like proteins through the 
activity of the well-known E1-E2-E3 
enzyme cascade, in which the E3 ubiq-
uitin ligase binds the substrate and 
recruits the ubiquitin transferase activity 
of the E2 ubiquitin-conjugating enzyme. 
In humans, more than 500 predicted E3 
ubiquitin ligases act on thousands of 
gene products and often recognize spe-
cifically modified forms of those proteins. 
Opposing this army of E3 ligases are 
?95 deubiquitinating enzymes (DUBs), 
proteases that cleave the isopeptide 
bond between the C-terminal glycine 
of ubiquitin and a side-chain lysine of a 
target protein or ubiquitin itself (Reyes-
Turcu et al., 2009). There are five distinct 
DUB domains, of which one is a metal-
loprotease (JAMM domain) and four are 222 Cell 138, July 24, 2009 ©2009 Elsevier Icysteine proteases (USP, OTU, MJD, 
and UCH domains). It remains gener-
ally unclear how DUBs recognize their 
substrates. We also only have a modest 
understanding of the biological roles for 
most DUBs (Nijman et al., 2005); some 
have been linked to ubiquitin processing, 
histone modification, cell-cycle and DNA 
repair, kinase signaling, and endocyto-
sis. With so much uncharted territory, 
how do we connect DUBs to their biol-
ogy? In this issue of Cell, Sowa and col-
leagues (2009) approach this problem by 
purifying and identifying by mass spec-
trometry 774 high-confidence interact-
ing proteins of 75 epitope-tagged DUBs 
(Figure 1). The authors further propose a 
standardized scoring method to quantify 
the confidence in the interactions they 
identify and to track improvements in the 
methodology itself.
The three keys to proteomic identifica-
tion of interacting proteins are the selec-
tivity of the purification, the accuracy of 
the mass spectrometric identification of 
proteins, and the bioinformatic and statis-
tical analysis of the proteomic hits. How 
do Sowa and colleagues approach these nc.steps? Using a retroviral expression vec-
tor, the authors establish stable cultured 
cell lines expressing hemagglutinin (HA) 
epitope-tagged versions of the DUBs. 
The tagged “bait” protein is immunopre-
cipitated along with interacting proteins 
from extracts of the cells by resin harbor-
ing anti-HA antibodies. These interact-
ing proteins are cleaved into small frag-
ments by trypsin, and duplicate samples 
from the purification are analyzed by liq-
uid chromatography followed by tandem 
mass spectrometry (LC-MS/MS) (Figure 
1). With this standard single-epitope tag 
affinity purification scheme, substantial 
nonspecific interacting proteins are also 
isolated. These “background” interac-
tions are partially corrected for by con-
trol purifications, including those with the 
other 74 DUBs. However, this purification 
approach may be improved by using two 
independent epitope tags and thus two 
sequential affinity purification steps to 
achieve a more selective purification. 
Another powerful method of stringent 
purification involves the specific isola-
tion of correctly localized proteins in the 
cell with green fluorescent protein tags 
(Cheeseman and Desai, 2005). For sys-
tematic approaches like that undertaken 
by Sowa et al., the burden of cloning 
multiple genes into tandem epitope tag 
vectors can be reduced by using recom-
bination-based systems (Torres et al., 
2009).
The scoring in protein identification 
by mass spectrometry uses the unique 
mass-to-charge ratio of individual pep-
tides and the proteomics database to 
link identified peptides to the predicted 
protein. The ion current or total spec-
tral counts (TSCs) generated by specific 
peptides is a quantitative measure of 
signal strength. Although the relation-
ship between the two is not perfectly 
understood, TSCs are correlated with 
the abundance of the peptides in the 
analyzed preparation. As the number of 
peptides from a single protein associated 
with a specific bait protein increases, the 
confidence of the interaction increases. 
Figure 1. Identifying and Classifying High-
Confidence Interacting Proteins
Sowa et al. (2009) affinity purify from cultured hu-
man cells 75 deubiquitinating enzymes and identi-
fy their interacting proteins by mass spectrometric 
analysis. They further develop and use a method 
called CompPASS to analyze the mass spectrom-
etry data to identify high-confidence interacting 
proteins and reveal potential biological implica-
tions for these interactions.To quantify and analyze the DUB inter-
actors they identified, Sowa and col-
leagues create a suite of software scripts 
called CompPASS. Within CompPASS, 
an automated MS/MS data-processing 
protocol constructs a data table listing 
the 75 baits and the TSCs for each of the 
candidate interactors. Two scores are 
calculated from this table. The Z score 
is a conventional performance score, 
whereas the D score takes into account 
the uniqueness of the interactions, the 
TSCs of the interactors, and the repro-
ducibility of interaction. High scores go 
to interactors that are unique and iden-
tified in replicates with high TSCs. For 
candidate interactors, the two scores are 
arrayed on a two dimensional D versus 
Z score plot. The authors define those 
interactors that fall into the plot quadrant 
with the highest of both scores as “high-
confidence interacting proteins.” In this 
analysis, they provide a compelling case 
for performing independent replicates 
of the purification (biological replicates) 
to strongly improve the discrimination 
between high-confidence interacting 
proteins and other candidate interac-
tors. This standardization of how protein 
interactions are quantified is valuable 
and can allow a researcher to compare 
results and track improvements to the 
methodology itself. A particularly flexible 
tool the authors use for the visualization 
of interactions between DUBs and the 
high-confidence interacting proteins as 
a network is the popular Cytoscape pro-
gram (Cline et al., 2007).
To validate their procedure, the authors 
compare the high-confidence interact-
ing proteins they identified for several 
well-studied DUBs with the literature. For 
example, the DUB ubiquitin-specific pro-
cessing protease 22 (USP22) is known to 
bind the SAGA transcriptional regulatory 
complex. In the Sowa et al. study, USP22 
has 28 high-confidence interacting pro-
teins, 14 of which are SAGA components 
or close homologs. Also, the four DUBs 
known to interact with the proteasome 
all show interactions in the study with a 
majority of or all known proteasome sub-
units. For further validation, the authors 
also test 40 predicted pairwise interac-
tions by standard coimmunoprecipitation-
 immunoblot experiments. These show 
a high success rate, but some caution 
must be exercised as some bias is inher-Cellent in assembling the tools to test specific 
examples. However, individual research-
ers can mine this resource of high-con-
fidence interacting proteins identified by 
Sowa et al. to generate a wealth of test-
able hypotheses.
To provide an overview of the DUB 
interacting proteins, Sowa et al. use 
standard Gene Ontogeny classes. They 
find, for example, that one-third of the 
high-confidence interacting proteins may 
be located in the nucleus. Furthermore, 
several of the interactions predict more 
specific links to chromatin processing or 
DNA damage repair pathways, RNA pro-
cessing pathways, the autophagy path-
way, and the VPC/Cdc48 AAA ATPase, 
a regulator of ubiquitination and endo-
plasmic reticulum-associated protein 
degradation. Specific protein domains 
are also strongly linked to DUBs, includ-
ing domains known to be involved in 
the ubiquitin-proteasome system. The 
authors further divide the DUBS into 
seven topological classes based on their 
interactors, using additional information 
from other protein-protein interaction 
and bioinformatic databases including 
the STRING (search tool for the retrieval 
of interacting genes/proteins), BioGRID 
(biological general repository for inter-
action data sets) (Stark et al., 2006), and 
MINT PPI (molecular interaction-protein-
protein interaction) databases. The larg-
est class is composed of high-confidence 
interacting proteins that only bind a single 
DUB (for example, p53 binding protein 1 
or 53BP1, which binds to USP28). Other 
classes are composed of DUBs that 
interact with common sets of proteins. 
This classification of interactions reveals 
intriguing biological links. For example, 
the DUB USP49 interacts with the three 
calcium-binding Centrin proteins that 
localize to centrosomes and are impor-
tant for their function, suggesting a con-
nection between DUBs and centrosome 
regulation. Another interesting cluster of 
DUBs binds to three structurally related 
protein-processing complexes, the sig-
nalosome, the eIF3 translation complex, 
and the proteasome, implying that the 
protein-processing pathways modulated 
by these complexes may be linked by 
deubiquitination.
The confidence of the interacting pro-
teins identified in this study derives from 
the accuracy of the mass spectrometry,  138, July 24, 2009 ©2009 Elsevier Inc. 223
the quantitative scoring method, and 
the biological replicates that were per-
formed. The current sensitivity of mass 
spectrometry, combined with available 
protein databases, makes protein iden-
tification accurate and efficient such that 
even weaker interactions can be identi-
fied. The approach taken by Sowa et al. 
to find high-confidence interaction pro-
teins of DUBs from mass spectrometry 
data is systematic and unbiased. Thus, 
it is highly valuable to those seeking to 
identify and analyze protein interactions 
by mass spectrometry. Although such 
efforts are in many cases accurate in 224 Cell 138, July 24, 2009 ©2009 Elsevier I
MicroRNAs (miRNAs) are 21–23 nt 
RNAs that interact with Argonaute (Ago) 
proteins to regulate gene expression 
in plants and animals through cleav-
age or translational repression of tar-
get mRNAs (Carthew and Sontheimer, 
2009). In animals, the processing steps 
required to transform initial primary 
miRNA transcripts (pri-miRNAs) to 
mature miRNAs are carried out by the 
RNase III enzymes Drosha (assisted by 
the RNA-binding protein DGCR8/Pasha 
in a complex known as the Micropro-
cessor) and Dicer (Kim et al., 2009) 
(Figure 1). Although RNA silencing in 
vertebrates is centered on endogenous 
RNAs, flies, worms, and plants utilize 
the small-interfering RNA (siRNA) path-
way to fight viral infection by using viral 
double-stranded RNA as a template for 
the synthesis of small effector RNAs 
(Ding and Voinnet, 2007). Two parallel 
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regulator of RNA silencing. They
antiviral resistance in flies, and isdelineating interactions, they remain in 
great need of a CompPASS to under-
stand where the findings lie on the bio-
logical map. The greatest value of the 
approach taken by Sowa et al. may be 
in the ability to link a protein of interest 
to a defined biological pathway, thereby 
allowing for more focused hypotheses 
and experiments.
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RNA silencing pathways exist in Droso-
phila with Dicer-1 and Ago1 supporting 
the miRNA pathway, and Dicer-2, Ago2, 
and the RNA-binding protein R2D2 
supporting the siRNA pathway (Figure 
1) (Carthew and Sontheimer, 2009). The 
findings reported by the Cherry and 
Thompson labs in this issue identify 
Ars2 as a new factor in the RNA silenc-
ing machinery that functions in antiviral 
defense in flies (Sabin et al., 2009) and 
cell proliferation in mammals (Gruber 
et al., 2009).
Mammalian cellular proliferation and 
intrinsic antiviral defense in Drosophila 
are seemingly unrelated processes, 
and it therefore comes as a surprise 
that a single protein factor is at the 
core of both mechanisms. In mam-
mals, a truncated version of Ars2 has 
been implicated in arsenic resistance, 
but the full-length protein regulates cell 
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Proteomics 9, 2888–2891.proliferation through a possible effect 
on RNA metabolism (Wilson et al., 
2008). Interestingly, the plant homolog 
of Ars2, SERRATE, is an essential fac-
tor in miRNA biogenesis (Grigg et al., 
2005) that interacts with the nuclear 
cap-binding complex (CBC) (Laubinger 
et al., 2008) and the RNase III enzyme 
Dicer-Like 1 (DCL1) (Dong et al., 2008).
In a search for factors mediating viral 
resistance in Drosophila, the Cherry 
lab performed a small-scale screen 
and found that loss of Ars2 results in a 
5-fold increase in infectivity for several 
RNA viruses in both cell culture and 
adult flies (Sabin et al., 2009). Given 
that viral infection is counteracted 
by siRNAs in Drosophila, the authors 
sought a connection between these 
two pathways. They observe a dramatic 
relief of siRNA-mediated silencing 
upon Ars2 knockdown and show that 
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